Inventor · disambiguated record
Laurence Legeai-Mallet
Also filed as: LEGEAI-MALLET LAURENCE
4 granted patents·11 pending applications·4 citations·filing 2012–2024
65Inventor score
Files withINST NAT SANTE RECH MED13INSTITUT NATIONAL DE LA SANTE ET DE LE RECH MEDICALE INSERM1NSTITUT NATIONAL DE LA SANTE ET DE LA RECH MEDICALE INSERM1
Top patents by PatentIndex Score
15 records- 0184US2024350490A1Antagonist of the fibroblast growth factor receptor 3 (fgfr3) for use in the treatment or the prevention of skeletal disorders linked with abnormal activation of fgfr3INST NAT SANTE RECH MED·Filed 2023·Application pending·0 cites
- 0282US9931341B2Antagonist of the fibroblast growth factor receptor 3 (FGFR3) for use in the treatment or the prevention of skeletal disorders linked with abnormal activation of FGFR3INST NAT SANTE RECH MED·Filed 2015·Granted Apr 3, 2018·2 cites·1 claims
- 0381US11357778B2Antagonist of the fibroblast growth factor receptor 3 (FGFR3) for use in the treatment or the prevention of skeletal disorders linked with abnormal activation of FGFR3INSTITUT NATIONAL DE LA SANTE ET DE LE RECH MEDICALE INSERM·Filed 2019·Granted Jun 14, 2022·2 cites·1 claims
- 0474US2023075776A1Antagonist of the fibroblast growth factor receptor 3 (fgfr3) for use in the treatment or the prevention of skeletal disorders linked with abnormal activation of fgfr3INST NAT SANTE RECH MED·Filed 2022·Application pending·0 cites
- 0566US12257232B2Methods and pharmaceutical compositions for the treatment of FGFR3-related chondrodysplasiasINST NAT SANTE RECH MED·Filed 2023·Granted Mar 25, 2025·0 cites·3 claims
- 0666US2024285626A1Infigratinib for treatment of fgfr3-related skeletal diseases during pregnancyINST NAT SANTE RECH MED·Filed 2024·Application pending·0 cites
- 0758US2018161327A1Antagonist of the fibroblast growth factor receptor 3 (fgfr3) for use in the treatment or the prevention of skeletal disorders linked with abnormal activation of fgfr3NSTITUT NATIONAL DE LA SANTE ET DE LA RECH MEDICALE INSERM·Filed 2018·Application pending·0 cites
- 0857US11951090B2Methods and pharmaceutical compositions for the treatment of FGFR3-related chondrodysplasiasINST NAT SANTE RECH MED·Filed 2019·Granted Apr 9, 2024·0 cites·1 claims
- 0955US2025041262A1Compositions for the treatment of fgfr3-related cognitive deficits with a catechinINST NAT SANTE RECH MED·Filed 2022·Application pending·0 cites
- 1055US2025041263A1Use of catechin for the treatment of fgfr-related bone repair and bone formation impairmentINST NAT SANTE RECH MED·Filed 2022·Application pending·0 cites
- 1152US2015011560A1Antagonist of the fibroblast growth factor receptor 3 (fgfr3) for use in the treatment or the prevention of skeletal disorders linked with abnormal activation of fgfr3INST NAT SANTE RECH MED·Filed 2012·Application pending·0 cites
- 1250US2023233553A1A new combination therapy for the treatment of fgfr3- related skeletal diseaseINST NAT SANTE RECH MED·Filed 2021·Application pending·0 cites
- 1347US2022040175A1Infigratinib for treatment of fgfr3-related skeletal diseases during pregnancyINST NAT SANTE RECH MED·Filed 2019·Application pending·0 cites
- 1445US2023241061A1Methods and pharmaceutical compositions for the treatment of fgfr3-related cognitive deficitINST NAT SANTE RECH MED·Filed 2021·Application pending·0 cites
- 1530US2018237424A1Fgfr3 antagonistsINST NAT SANTE RECH MED·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Laurence Legeai-Mallet files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →